Laboratory Corporation Of America Holdings LH.N :
* LABCORP ANNOUNCES 2023 FIRST QUARTER RESULTS
* LABCORP : FULL-YEAR 2023 GUIDANCE: ADJUSTED EPS NARROWED
TO
$16.25 TO $17.75 WITH MIDPOINT UNCHANGED AND FREE CASH FLOW
REMAINS AT $1.0 BILLION TO $1.2 BILLION
* LABCORP - REVENUE: Q1 OF $3.8 BILLION VERSUS $3.9 BILLION
LAST
YEAR
* LABCORP - ADJUSTED EPS: Q1 OF $3.82
* LABCORP - PLANNED SPIN OF CLINICAL DEVELOPMENT BUSINESS
REMAINS
ON SCHEDULE FOR MID-2023
* LABCORP - DILUTED EPS: Q1 OF $2.39
* Q1 EARNINGS PER SHARE VIEW $3.96, REVENUE VIEW $3.69
BILLION --
REFINITIV IBES DATA
* FY2023 EARNINGS PER SHARE VIEW $17.17 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nPn7KYrzCa
Further company coverage: LH.N